JPH112606A - Chirality analysis method - Google Patents
Chirality analysis methodInfo
- Publication number
- JPH112606A JPH112606A JP17096797A JP17096797A JPH112606A JP H112606 A JPH112606 A JP H112606A JP 17096797 A JP17096797 A JP 17096797A JP 17096797 A JP17096797 A JP 17096797A JP H112606 A JPH112606 A JP H112606A
- Authority
- JP
- Japan
- Prior art keywords
- chirality
- spectrum
- functional group
- ring
- circularly polarized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 24
- 125000000524 functional group Chemical group 0.000 claims abstract description 20
- 238000001228 spectrum Methods 0.000 claims abstract description 20
- 230000005284 excitation Effects 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims description 5
- 239000000523 sample Substances 0.000 abstract description 20
- 230000035945 sensitivity Effects 0.000 abstract description 14
- 125000001624 naphthyl group Chemical group 0.000 abstract description 3
- 125000005583 coronene group Chemical group 0.000 abstract description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 abstract description 2
- 150000004032 porphyrins Chemical group 0.000 abstract description 2
- 125000005581 pyrene group Chemical group 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 6
- 239000011149 active material Substances 0.000 abstract 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 34
- 238000005259 measurement Methods 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 238000000853 optical rotatory dispersion Methods 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 238000001917 fluorescence detection Methods 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 238000000695 excitation spectrum Methods 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- NSNPSJGHTQIXDO-UHFFFAOYSA-N naphthalene-1-carbonyl chloride Chemical compound C1=CC=C2C(C(=O)Cl)=CC=CC2=C1 NSNPSJGHTQIXDO-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- PFURGBBHAOXLIO-PHDIDXHHSA-N trans-cyclohexane-1,2-diol Chemical compound O[C@@H]1CCCC[C@H]1O PFURGBBHAOXLIO-PHDIDXHHSA-N 0.000 description 3
- -1 1,2-trans-cyclohexane-diol bisnaphthoate Chemical compound 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- XNLBCXGRQWUJLU-UHFFFAOYSA-N naphthalene-2-carbonyl chloride Chemical compound C1=CC=CC2=CC(C(=O)Cl)=CC=C21 XNLBCXGRQWUJLU-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 1
- LZPGMNYCUOATIX-UHFFFAOYSA-N 6-methoxynaphthalene-1-carbonyl chloride Chemical compound ClC(=O)C1=CC=CC2=CC(OC)=CC=C21 LZPGMNYCUOATIX-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- BXSABLKMKAINIU-UHFFFAOYSA-N Oubagenin Natural products CC12CC(O)C(C3(C(O)CC(O)CC3(O)CC3)CO)C3C1(O)CCC2C1=CC(=O)OC1 BXSABLKMKAINIU-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000005577 anthracene group Chemical group 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical class CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- PFURGBBHAOXLIO-UHFFFAOYSA-N cyclohexane-1,2-diol Chemical compound OC1CCCCC1O PFURGBBHAOXLIO-UHFFFAOYSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 125000003719 estrone group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- BXSABLKMKAINIU-QOHCMMFCSA-N ouabagenin Chemical compound C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5([C@H](O)C[C@H](O)C[C@@]5(O)CC4)CO)[C@H](O)C[C@@]32C)=CC(=O)OC1 BXSABLKMKAINIU-QOHCMMFCSA-N 0.000 description 1
- 229910001392 phosphorus oxide Inorganic materials 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- FNRNHFMKSCPBDA-UHFFFAOYSA-N pyrene-1-carbonyl chloride Chemical compound C1=C2C(C(=O)Cl)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 FNRNHFMKSCPBDA-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- VSAISIQCTGDGPU-UHFFFAOYSA-N tetraphosphorus hexaoxide Chemical compound O1P(O2)OP3OP1OP2O3 VSAISIQCTGDGPU-UHFFFAOYSA-N 0.000 description 1
- 229960003433 thalidomide Drugs 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明はキラリティ解析方
法、特にその測定感度の向上に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a chirality analysis method, and more particularly to an improvement in measurement sensitivity.
【0002】[0002]
【従来の技術】薬物や毒物、あるいは生体内に存在する
機能性生体成分などの生理活性物質の多くはいわゆるキ
ラリティを有し、その生理活性がキラリティすなわち、
物質の絶対構造、立体構造、あるいは立体配置などに強
く依存することが広く知られている。例えば、アミノ酸
の一つであるアスパラギンのR体は甘いが、S体は苦
い。エストロンの(+)体は女性ホルモンとして機能す
るが、(−)体にはその機能がない。サリドマイドのR
体には催眠作用があるが、S体には催奇性があるなどの
事例が周知である。2. Description of the Related Art Many physiologically active substances such as drugs, toxic substances, and functional biological components existing in a living body have so-called chirality.
It is widely known that a substance strongly depends on an absolute structure, a three-dimensional structure, or a three-dimensional configuration of a substance. For example, the R form of asparagine, one of the amino acids, is sweet, while the S form is bitter. The (+) form of estrone functions as a female hormone, but the (-) form does not. Thalidomide R
It is well known that the body has a hypnotic effect but the S body has a teratogenic effect.
【0003】このため、これらの生理活性物質の探索、
合成、代謝、作用などの研究においては、その物質のキ
ラリティの把握がきわめて重要なこととされてきた。し
かしながら、このキラリティのみ異なる光学異性体は、
一般に化学的性質は同一ないし極めて近似しており、こ
のためキラリティを把握し、解析する手段は、単結晶X
線構造解析か、カイロオプティカルスペクトロスコピー
(円二色性スペクトル(CD)、旋光分散スペクトル
(ORD)等の総称)に限られている。この中で、CD
は、試料が溶液状で測定可能なこと、測定操作が比較的
手軽なことから、この種の研究に広く用いられてきた。[0003] Therefore, search for these physiologically active substances,
In studies of synthesis, metabolism, action, and the like, it has been considered extremely important to understand the chirality of the substance. However, optical isomers that differ only in this chirality
In general, the chemical properties are the same or very similar. Therefore, the means for grasping and analyzing the chirality is a single crystal X
It is limited to line structure analysis or chirooptical spectroscopy (general term such as circular dichroism spectrum (CD) and optical rotatory dispersion spectrum (ORD)). Among them, CD
Has been widely used for this kind of research because the sample can be measured in a solution state and the measurement operation is relatively easy.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、試料物
質が示す左円偏光の光吸収と、右円偏光の光吸収の差で
あるCDは、適用に当たって次のような2つの限界があ
る。 適当なCDスペクトルが観測されるためには、対象と
なる試料分子に適当な光吸収の元となる発色団が含まれ
ている必要がある。発色団が含まれていない物質では適
当なCDスペクトルが観測されず、適用ができない。However, the CD, which is the difference between the left-handed circularly polarized light absorption and the right-handed circularly polarized light absorption exhibited by the sample material, has the following two limitations in application. In order for an appropriate CD spectrum to be observed, the target sample molecule needs to contain a chromophore that is a source of appropriate light absorption. In the case of a substance containing no chromophore, no appropriate CD spectrum is observed, so that it cannot be applied.
【0005】一方、CDのない試料でもORDは観測さ
れるが、このような場合のORDスペクトルは一般に単
調で構造の解析にはあまり役立たない。逆にCDがある
場合には、ORDスペクトルは情報としてはCDと等価
でしかないにもかかわらず形がCDよりも複雑となり、
その上感度も低い。従って、ORDはCDの限界を補う
ものではない。 CDの感度は光吸収そのものに比べ、至適な試料の場
合でも1/100、通常は1/1000〜1/1000
0と低く、それを補うために比較的高い濃度の測定試料
が必要となる。[0005] On the other hand, although ORD is observed even in a sample without CD, the ORD spectrum in such a case is generally monotonous and is not very useful for structural analysis. Conversely, if there is a CD, the ORD spectrum is more complex in shape than the CD, although the information is only equivalent to the CD.
Moreover, the sensitivity is low. Therefore, ORD does not compensate for the limitations of CD. The sensitivity of the CD is 1/100 even in the case of the optimum sample, usually 1/1000 to 1/1000 compared to the light absorption itself.
It is as low as 0, and a relatively high concentration of the measurement sample is required to make up for it.
【0006】しかしながら、対象となる生理活性物質
は、大量の採取が難しいことが一般的であり、測定・解
析に当たって大量の試料確保に多大の努力が払われてい
る。このような努力を軽減し、また大量の試料を採取す
ることが困難であるため実際には着手できなかった研究
分野を切り開くために、キラリティ解析に当たっての測
定手段の感度の向上が希求されている。本発明は前記従
来技術に鑑みなされたものであり、その目的はキラリテ
ィ解析に当たっての検出感度を大きく向上させることに
ある。However, it is generally difficult to collect a large amount of a target physiologically active substance, and a great deal of effort has been made to secure a large amount of sample in measurement and analysis. In order to reduce such efforts and to open up research fields that could not be undertaken because it is difficult to collect a large amount of samples, it is desired to improve the sensitivity of measurement means in chirality analysis. . The present invention has been made in view of the above prior art, and has as its object to greatly improve the detection sensitivity in chirality analysis.
【0007】[0007]
【課題を解決するための手段】前記目的を達成するため
に本発明にかかるキラリティ解析方法は、キラリティを
有する物質に蛍光性官能基を導入し、それを左右の円偏
光で励起してそれぞれの蛍光強度を測定し、左円偏光励
起と右円偏光励起の蛍光強度差情報より該物質のキラリ
ティを解析することを特徴とする。また、本発明におい
て、前記左右の円偏光は実質的に同一波長で切り替えて
照射し、かつ照射波長を順次変更し、左円偏光励起と右
円偏光励起の蛍光強度差を波長と相関させてスペクトル
を得、該スペクトルより前記物質のキラリティを解析す
ることが好適である。In order to achieve the above object, a chirality analysis method according to the present invention comprises introducing a fluorescent functional group into a substance having chirality, exciting it with left and right circularly polarized light, It is characterized in that the fluorescence intensity is measured, and the chirality of the substance is analyzed from the difference information of the fluorescence intensity between the left circularly polarized light excitation and the right circularly polarized light excitation. Further, in the present invention, the left and right circularly polarized light is irradiated by switching at substantially the same wavelength, and the irradiation wavelength is sequentially changed, and the fluorescence intensity difference between left circularly polarized light excitation and right circularly polarized light excitation is correlated with the wavelength. It is preferable to obtain a spectrum and analyze the chirality of the substance from the spectrum.
【0008】[0008]
【発明の実施形態】以下、本発明の好適な実施形態につ
いて図面を参照しつつ説明する。本発明においては、前
述したように生理活性物質などのキラリティを有する物
質に、化学的手段を用いて蛍光性官能基を導入して蛍光
物質とし、円二色性蛍光励起スペクトルあるいは蛍光検
出円二色性スペクトルを測定して、対象となる試料物質
のキラリティ解析に供する。ここで、蛍光性官能基とし
ては、特に限定されるものではないが、ナフタレン環、
アントラセン環、ピレン環、ペリレン環、コロネン環、
ポルフィリン環等を含む基が蛍光強度が強く、かつそれ
自身の対称性が高く、電子状態や吸収・蛍光の遷移モー
メントの方向などが十分に研究されていて、後の解析に
好都合である。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Preferred embodiments of the present invention will be described below with reference to the drawings. In the present invention, as described above, a fluorescent functional group is introduced into a substance having chirality, such as a physiologically active substance, using a chemical means to form a fluorescent substance. The color spectrum is measured and used for chirality analysis of the target sample substance. Here, the fluorescent functional group is not particularly limited, but a naphthalene ring,
Anthracene ring, pyrene ring, perylene ring, coronene ring,
A group containing a porphyrin ring or the like has high fluorescence intensity and high symmetry of itself, and the electronic state and the direction of the transition moment of absorption / fluorescence have been sufficiently studied, which is convenient for later analysis.
【0009】円二色性蛍光励起スペクトルとは、試料に
単色化した左と右の円偏光を交互に照射して励起したと
きの蛍光強度を測定し、左の円偏光で励起したときと、
右の円偏光で励起したときの蛍光強度の差を波長に対し
て記録するものである。また、蛍光検出円二色性スペク
トルは、その蛍光強度の差を平均の蛍光強度で割ったも
のを波長に対して記録するものである。Circular dichroic fluorescence excitation spectrum refers to the measurement of the fluorescence intensity when the sample is excited by alternately irradiating the sample with monochromatic left and right circularly polarized light, and when the sample is excited with the left circularly polarized light,
The difference in fluorescence intensity when excited by the right circularly polarized light is recorded with respect to the wavelength. The fluorescence detection circular dichroism spectrum is obtained by dividing the difference between the fluorescence intensities by the average fluorescence intensity with respect to the wavelength.
【0010】なお、これらのスペクトルを採取する際に
は、分光器より順次波長走査された単色光を直線偏光化
した後、光弾性変調素子などに導入し、その変調周波数
により左右の円偏光を生成し、試料に照射することが好
適である。これら2つのスペクトルの感度は、従来のC
DやORDに比べて1〜3桁高く、望まれていた感度向
上が実現される。また、これらの方法によって、元々発
色団のなかった物質についても、そのキラリティを反映
するスペクトルが得られるようになり、測定・解析が可
能になる。When these spectra are collected, monochromatic light sequentially wavelength-scanned by a spectroscope is linearly polarized, and then introduced into a photoelastic modulator, and left and right circularly polarized light is modulated according to the modulation frequency. Preferably, it is generated and irradiated on the sample. The sensitivity of these two spectra is the conventional C
Compared with D and ORD, the sensitivity is one to three orders of magnitude higher, and the desired sensitivity improvement is realized. In addition, by these methods, a spectrum reflecting the chirality of a substance originally having no chromophore can be obtained, and measurement and analysis can be performed.
【0011】[0011]
【実施例】以下、図面を参照しつつ、本発明のより具体
的な実施例を説明する。2R,3R−ブタンジオール この2R,3R−ブタンジオールは生理活性物質ではな
いが、本発明の効果を確認するために選択したモデル物
質であり、図1に示すような構造を有している。DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, a more specific embodiment of the present invention will be described with reference to the drawings. 2R, 3R-butanediol Although this 2R, 3R-butanediol is not a physiologically active substance, it is a model substance selected in order to confirm the effects of the present invention, and has a structure as shown in FIG.
【0012】この物質のCDスペクトルとORDスペク
トルを図2及び図3に示す。 CDスペクトル測定条件 セル長:10mm 濃度:0.1% 溶媒:H2O 測定温度:室温 レンジ:600−200nm バンド幅:1.0nm 積算:2回 レスポンス:2秒 走査速度:50nm/minThe CD spectrum and the ORD spectrum of this substance are shown in FIGS. CD spectrum measurement conditions Cell length: 10 mm Concentration: 0.1% Solvent: H 2 O Measurement temperature: room temperature Range: 600-200 nm Band width: 1.0 nm Integration: twice Response: 2 seconds Scanning speed: 50 nm / min
【0013】ORDスペクトル測定条件 セル長:10mm 濃度:0.8% 溶媒:H2O 測定温度:室温 レンジ:600−200nm バンド幅:1.0nm 積算:2回 レスポンス:2秒 走査速度:50nm/min この分子には発色団が含まれていないので、CDスペク
トルは観察されていない。ORDスペクトルも、単調
で、構造の解析には役立たない。ORD spectrum measurement conditions Cell length: 10 mm Concentration: 0.8% Solvent: H 2 O Measurement temperature: room temperature Range: 600-200 nm Band width: 1.0 nm Integration: twice Response: 2 seconds Scanning speed: 50 nm / min No CD spectrum is observed since this molecule does not contain a chromophore. The ORD spectrum is also monotonous and is not useful for structural analysis.
【0014】そこで、このブタンジオールに含まれるO
H基を利用して、β−ナフトイルクロリドと反応させ、
蛍光性官能基であるナフチル基を導入する。そうする
と、この試薬は2R,3R−ブタンジオールと縮合反応
し、2R,3R−ビスナフトイルブタンジオール(図
4)となる。Therefore, the O contained in this butanediol is
Using H group, react with β-naphthoyl chloride,
A naphthyl group, which is a fluorescent functional group, is introduced. Then, this reagent undergoes a condensation reaction with 2R, 3R-butanediol to give 2R, 3R-bisnaphthoylbutanediol (FIG. 4).
【0015】この試料の1.78ppmのアセトニトリル
溶液のCDスペクトルを図5に示す。導入された発色団
によってCDを持つようになり、エキシトン分裂型のス
ペクトル構造が得られ、その分子のキラリティの解析が
可能となる。 CDスペクトル測定条件 セル長:10mm 濃度:0.000178% 溶媒:CH3CN 測定温度:室温 レンジ:350−190nm バンド幅:1.0nm 積算:2回 レスポンス:2秒 走査速度:50nm/minFIG. 5 shows the CD spectrum of a 1.78 ppm acetonitrile solution of this sample. The introduced chromophore causes the chromophore to have a CD, obtains an exciton splitting type spectral structure, and enables analysis of the chirality of the molecule. CD spectrum measurement conditions Cell length: 10 mm Concentration: 0.000178% Solvent: CH 3 CN Measurement temperature: room temperature Range: 350-190 nm Band width: 1.0 nm Integration: twice Response: 2 seconds Scanning speed: 50 nm / min
【0016】さらに、この試料を1/100に希釈して
17.8ppbとし、そのCDスペクトル、蛍光検出CD
スペクトル及び円二色性蛍光励起スペクトルを測定した
ものを、それぞれ図6,7,8に示す。 蛍光検出CDスペクトル測定条件 濃度:1.78×10-6% 溶媒:CH3CN 測定温度:室温 レンジ:310−190nm バンド幅:5.0nm 積算:6回 レスポンス:2秒 走査速度:50nm/minFurther, this sample was diluted to 1/100 to 17.8 ppb, and its CD spectrum, fluorescence detection CD
The measured spectrum and circular dichroic fluorescence excitation spectrum are shown in FIGS. Fluorescence detection CD spectrum measurement conditions Concentration: 1.78 × 10 -6 % Solvent: CH 3 CN Measurement temperature: room temperature Range: 310-190 nm Band width: 5.0 nm Integration: 6 times Response: 2 seconds Scanning speed: 50 nm / min
【0017】蛍光励起CDスペクトル測定条件 濃度:1.78×10-6% 溶媒:CH3CN 測定温度:室温 レンジ:310−190nm バンド幅:5.0nm 積算:6回 レスポンス:2秒 走査速度:50nm/minFluorescence excitation CD spectrum measurement conditions Concentration: 1.78 × 10 −6 % Solvent: CH 3 CN Measurement temperature: room temperature Range: 310-190 nm Band width: 5.0 nm Integration: 6 times Response: 2 seconds Scanning speed: 50nm / min
【0018】図6より明らかなように、CDスペクトル
はノイズと同程度の大きさとなって、もはや判別が困難
であるが、蛍光検出CDスペクトル(図7)、及び円二
色性蛍光励起スペクトル(図8)によれば、十分なS/
N比をもって観察される。この例で計算したCDに対す
る円二色性蛍光励起スペクトルの感度比は約20倍であ
る。このように、本発明を適用すると、元々発色団がな
くてCDスペクトルの測定もできなかった物質につい
て、従来ではおよそ望めなかった感度をもって、キラリ
ティを反映するスペクトル情報を得ることができる。発
色団があってCDが観測できても、感度が十分でないと
きには、本発明を適用すると、感度を桁単位で向上させ
ることができる。As is clear from FIG. 6, the CD spectrum has the same size as the noise and is difficult to discriminate, but the fluorescence detection CD spectrum (FIG. 7) and the circular dichroic fluorescence excitation spectrum (FIG. 7). According to FIG. 8), sufficient S /
Observed with N ratio. The sensitivity ratio of the circular dichroism fluorescence excitation spectrum to CD calculated in this example is about 20 times. As described above, when the present invention is applied, spectral information that reflects chirality can be obtained with a sensitivity that could not be expected in the past with respect to a substance that did not originally have a chromophore and could not measure a CD spectrum. If the sensitivity is not sufficient even if a CD can be observed due to the presence of a chromophore, application of the present invention can improve the sensitivity by an order of magnitude.
【0019】また、本発明では光吸収に比べて波長選択
性が高い蛍光で試料物質のキラリティを観測する。例え
ば分子の中に不斉中心が複数存在するような場合で、そ
のままの状態でCD測定を行うと、得られたCDバンド
がどの不斉中心を反映しているのかの帰属判断が難し
く、解析が困難な場合も少なくない。このような場合で
もキラリティを調べようとする不斉中心の構造を反映す
るような位置に蛍光性の官能基を導入し、本発明のスペ
クトルを測定すると、蛍光検出のもつ高い選択性によっ
てスペクトルがシンプルとなり、局所的な構造情報を得
ることが可能となり、物質分子の構造を位置の選択性を
もって解析することができる。Further, in the present invention, the chirality of the sample substance is observed with fluorescence having wavelength selectivity higher than that of light absorption. For example, if there are multiple asymmetric centers in a molecule and CD measurement is performed as it is, it is difficult to determine which asymmetric center is reflected in the obtained CD band, and analysis Is often difficult. Even in such a case, when a fluorescent functional group is introduced at a position that reflects the structure of the chiral center whose chirality is to be examined, and the spectrum of the present invention is measured, the spectrum is determined by the high selectivity of fluorescence detection. It is simple, and it is possible to obtain local structural information, and it is possible to analyze the structure of a substance molecule with positional selectivity.
【0020】蛍光性官能基の導入例 蛍光性官能基を化学的に導入するために、導入される化
合物が有する比較的化学的に活性な官能基が利用され
る。例えば水酸基(−OH)、カルボキシル基(−CO
OH)をもつ場合にはエステル化反応を利用して導入で
きる。アミノ基(−NH2)には、オルトフタルアルデ
ヒドやフロロレスカミン、5−ジメチルアミノ−1−ナ
フタレンスルホニルクロリド(通称ダンシルクロリド)
などとの反応が利用できる。 Example of Introduction of Fluorescent Functional Group In order to chemically introduce a fluorescent functional group, a relatively chemically active functional group of a compound to be introduced is used. For example, a hydroxyl group (-OH), a carboxyl group (-CO
OH) can be introduced by utilizing an esterification reaction. Amino group is (-NH 2), OPA and fluorosilicone fluorescamine, 5-dimethylamino-1-naphthalenesulfonyl chloride (aka dansyl chloride)
Reactions such as can be used.
【0021】本発明の一実施例として、試料1,2−ジ
ヒドロキシシクロヘキサンの2つの−OH基にエステル
化によってナフトイル基を導入する手順を示す。 1.温風で乾燥したガラス製反応容器(5mlナス型フラ
スコ)を用意し、この中に乾燥させた試料5mgを入れ、
中の空気を不活性ガス(アルゴンガス)に置換する。 2.5酸化リンを入れたデシケータ中に1日おいて乾燥
させた触媒(0.1当量の4−ジメチルアミノピリジ
ン;0.53mg)と活性化剤(4当量のトリフロロメタ
ンスルホン酸銀;44mg)を、前記ガラス製容器内に入
れる。As one example of the present invention, a procedure for introducing a naphthoyl group into two 1,2-OH groups of a sample 1,2-dihydroxycyclohexane by esterification will be described. 1. A glass reaction vessel (5 ml eggplant type flask) dried with warm air was prepared, and 5 mg of the dried sample was placed therein.
The air inside is replaced with an inert gas (argon gas). 2.5 day dry catalyst in a desiccator over phosphorus oxide (0.1 equivalent of 4-dimethylaminopyridine; 0.53 mg) and activator (4 equivalent of silver trifluoromethanesulfonate; 44 mg) in the glass container.
【0022】3.環流しておいたピリジン0.5mlをガ
ラス製シリンジを用いて加え、マグネチックスターラー
で撹拌して溶解させる。 4.誘導体化試薬である2−ナフトイルクロリド66mg
(4当量)を加え、アルミホイルで容器全体を包み遮光
し、室温下で10時間撹拌しながら反応させる。 5.反応終了後、蒸留水を1滴加え、30分間撹拌し、
過剰の誘導体化試薬を分解させる。 6.アルミホイルを取り除き、ベンゼン2mlを加え、激
しく撹拌する。3. 0.5 ml of refluxed pyridine is added using a glass syringe, and the mixture is stirred and dissolved with a magnetic stirrer. 4. 66 mg of 2-naphthoyl chloride as a derivatization reagent
(4 equivalents), wrap the whole container with aluminum foil, shield from light, and react at room temperature with stirring for 10 hours. 5. After completion of the reaction, add one drop of distilled water, stir for 30 minutes,
Decompose excess derivatizing reagent. 6. Remove the aluminum foil, add 2 ml of benzene and stir vigorously.
【0023】7.無水硫酸ナトリウムを薬さじ1杯加え
る。これを無水硫酸ナトリウムのカラムに通し、ベンゼ
ンで溶出し、水分と固形分を除く。 8.ロータリーエバポレータでベンゼンを蒸発除去し、
さらに真空ポンプで減圧してピリジンを除去する。 9.固形分に1mlのヘキサン/酢酸エチル(2:1)を
加えて懸濁液とし、これをアルミナのカラムに乗せ、酢
酸エチル2mlで溶出させて酸性成分を除去する。 10.溶出液を蒸発乾固した後、0.5mlのクロロホルム
に溶解し、シリカゲルの薄層クロマトグラフィーで展開
液にベンゼン/酢酸エチル(9:1)を用いて精製す
る。7. Add 1 tablespoon of anhydrous sodium sulfate. This is passed through a column of anhydrous sodium sulfate and eluted with benzene to remove water and solids. 8. The benzene is removed by evaporation using a rotary evaporator,
Further, the pressure is reduced by a vacuum pump to remove pyridine. 9. 1 ml of hexane / ethyl acetate (2: 1) is added to the solid to form a suspension, which is applied to an alumina column and eluted with 2 ml of ethyl acetate to remove acidic components. Ten. The eluate is evaporated to dryness, dissolved in 0.5 ml of chloroform, and purified by thin-layer chromatography on silica gel using benzene / ethyl acetate (9: 1) as a developing solution.
【0024】なお、次に各種物質の蛍光性官能基導入例
を示す。導入例1 1,2−トランス−シクロヘキサン−ジオー
ル 図9に示すように、1,2−トランス−シクロヘキサン
−ジオール(a)に対しては、ナフトイルクロライド
(Naph−Cl)と反応させ、1,2−トランス−シ
クロヘキサン−ジオール ビスナフトエート(a−1)
にする方法、アンスロイルクロライド(Anth−C
l)と反応させ、1,2−トランス−シクロヘキサン−
ジオール ビスアンスロエート(a−2)にする方法、
6−メトキシナフトイルクロライド(MeONaph−
Cl)と反応させ、1,2−トランス−シクロヘキサン
−ジオール ビス−6−メトキシ−2−ナフトエート
(a−3)にする方法などが挙げられる。Next, examples of introducing fluorescent functional groups into various substances will be described. Introduction Example 1, 1,2-trans-cyclohexane-dio
As shown in FIG. 9, the 1,2-trans-cyclohexane-diol (a) was reacted with naphthoyl chloride (Naph-Cl), and the 1,2-trans-cyclohexane-diol bisnaphthoate (a- 1)
Anthroyl chloride (Anth-C
l) and reacting with 1,2-trans-cyclohexane-
A method for preparing diol bisanthroate (a-2),
6-methoxynaphthoyl chloride (MeONaph-
Cl) to give 1,2-trans-cyclohexane-diol bis-6-methoxy-2-naphthoate (a-3).
【0025】導入例2 5−コレスタン 図10に示すように、5−コレスタン(b)に対して
は、アンスロイルクロライド(Anth−Cl)を反応
させ、5−コレスタン ビスナフトエート(b−2)と
する方法、1−ピレンカルボニルクロライド(Py−C
l)と反応させ、5−コレスタンビスピレンカルボキシ
レート(b−4)とする方法等が挙げられる。導入例3 ウアバゲニン 図11に示すように、ウアバゲニン(c)に対しては、
ナフトイルクロライド(Naph−Cl)と反応させ、
ウアバゲニン 1,3,19−トリナフトエート(c−
1)とする方法などが挙げられる。 Introduction Example 2 5-Cholestane As shown in FIG. 10, 5-cholestane (b) is reacted with anthroyl chloride (Anth-Cl) to give 5-cholestane bisnaphthoate (b-2). Method, 1-pyrene carbonyl chloride (Py-C
1) to give 5-cholestanebispyrenecarboxylate (b-4). Introduction Example 3 Ouagegenin As shown in FIG. 11, for ouagegenin (c),
Reacting with naphthoyl chloride (Naph-Cl),
Oubergenin 1,3,19-trinaphthoate (c-
1) and the like.
【0026】[0026]
【発明の効果】以上説明したように本発明にかかるキラ
リティ解析方法によれば、キラリティを有する物質に蛍
光性官能基を導入し、左円偏光励起と右円偏光励起時の
蛍光強度差情報よりキラリティを解析することとしたの
で、大幅な感度向上を図ることができる。As described above, according to the chirality analysis method of the present invention, a fluorescent functional group is introduced into a substance having chirality, and information on the difference in fluorescence intensity between left circularly polarized light excitation and right circularly polarized light excitation is obtained. Since the chirality is analyzed, it is possible to significantly improve the sensitivity.
【図1】本発明の一実施例で試料として用いた2R,3
R−ブタンジオールの立体構造の説明図である。FIG. 1 shows 2R, 3 used as a sample in one embodiment of the present invention.
It is explanatory drawing of the three-dimensional structure of R-butanediol.
【図2】前記2R,3R−ブタンジオールのCDスペク
トル図である。FIG. 2 is a CD spectrum diagram of the 2R, 3R-butanediol.
【図3】前記2R,3R−ブタンジオールのORDスペ
クトル図である。FIG. 3 is an ORD spectrum diagram of the 2R, 3R-butanediol.
【図4】本発明の一実施例で試料として用いた2R,3
R−ブタンジオールの蛍光官能基修飾体である2R,3
R−ビス−ナフトイルブタンジオールの立体構造の説明
図である。FIG. 4 shows 2R, 3 used as a sample in one embodiment of the present invention.
2R, 3 which is a modified fluorescent functional group of R-butanediol
It is explanatory drawing of the three-dimensional structure of R-bis-naphthoylbutanediol.
【図5】2R,3R−ビス−ナフトイルブタンジオール
(1.78ppm)のCDスペクトル図である。FIG. 5 is a CD spectrum diagram of 2R, 3R-bis-naphthoylbutanediol (1.78 ppm).
【図6】2R,3R−ビス−ナフトイルブタンジオール
(17.8ppb)のCDスペクトル図である。FIG. 6 is a CD spectrum diagram of 2R, 3R-bis-naphthoylbutanediol (17.8 ppb).
【図7】2R,3R−ビス−ナフトイルブタンジオール
(17.8ppb)の蛍光検出CDスペクトル図であ
る。FIG. 7 is a fluorescence detection CD spectrum of 2R, 3R-bis-naphthoylbutanediol (17.8 ppb).
【図8】2R,3R−ビス−ナフトイルブタンジオール
(17.8ppb)の円二色性蛍光励起スペクトル図で
ある。FIG. 8 is a diagram showing a circular dichroic fluorescence excitation spectrum of 2R, 3R-bis-naphthoylbutanediol (17.8 ppb).
【図9】1,2−トランス−シクロヘキサン−ジオール
への蛍光性官能基の導入例の説明図である。FIG. 9 is an explanatory diagram of an example of introducing a fluorescent functional group into 1,2-trans-cyclohexane-diol.
【図10】5−コレスタンへの蛍光性官能基の導入例の
説明図である。FIG. 10 is an explanatory diagram of an example of introduction of a fluorescent functional group into 5-cholestane.
【図11】ウアバゲニンへの蛍光性官能基の導入例の説
明図である。FIG. 11 is an explanatory diagram of an example of introduction of a fluorescent functional group into ouabagenin.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 中西 香爾 アメリカ合衆国 10027 ニューヨーク州 ニューヨーク リバーサイドドライブ 560 (72)発明者 ニーナ ベローバ アメリカ合衆国 10027 ニューヨーク州 ニューヨーク 119ストリート ウエス ト400 (72)発明者 董 建国 アメリカ合衆国 11737 ニューヨーク州 エルムハースト 42アヴェニュー 94− 16 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Koji Nakanishi United States 10027 New York, New York Riverside Drive 560 (72) Inventor Nina Verova United States 10027 New York, New York 119 Street West 400 (72) Inventor Tong Founding United States 11737 New York Elmhurst Province 42 Avenue 94-16
Claims (2)
を導入し、それを左右の円偏光で励起してそれぞれの蛍
光強度を測定し、左円偏光励起と右円偏光励起の蛍光強
度差情報より該物質のキラリティを解析することを特徴
とするキラリティ解析方法。1. A fluorescent functional group is introduced into a substance having chirality, and the fluorescent functional group is excited with left and right circularly polarized light to measure the respective fluorescence intensities. A chirality analysis method characterized by further analyzing the chirality of the substance.
の円偏光を実質的に同一波長で切り替えて照射し、かつ
照射波長を順次変更し、左円偏光励起と右円偏光励起の
蛍光強度差を波長と相関させてスペクトルを得、該スペ
クトルより前記物質のキラリティを解析することを特徴
とするキラリティ解析方法。2. The method according to claim 1, wherein the left and right circularly polarized lights are illuminated while being switched at substantially the same wavelength, and the irradiation wavelengths are sequentially changed, so that the fluorescence intensity of the left circularly polarized light excitation and the right circularly polarized light excitation is changed. A chirality analysis method characterized by obtaining a spectrum by correlating the difference with a wavelength and analyzing the chirality of the substance from the spectrum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17096797A JPH112606A (en) | 1997-06-12 | 1997-06-12 | Chirality analysis method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17096797A JPH112606A (en) | 1997-06-12 | 1997-06-12 | Chirality analysis method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH112606A true JPH112606A (en) | 1999-01-06 |
Family
ID=15914693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17096797A Pending JPH112606A (en) | 1997-06-12 | 1997-06-12 | Chirality analysis method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH112606A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004070364A1 (en) * | 2003-02-06 | 2004-08-19 | Japan Science And Technology Agency | Method for the determination of absolute configuration of chiral compounds |
| WO2007088947A1 (en) | 2006-02-02 | 2007-08-09 | National University Corporation NARA Institute of Science and Technology | Circular dichroism fluorescent microscope |
| CN112782122A (en) * | 2019-11-04 | 2021-05-11 | 北京大学 | Device and method for measuring chirality of one-dimensional material |
-
1997
- 1997-06-12 JP JP17096797A patent/JPH112606A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004070364A1 (en) * | 2003-02-06 | 2004-08-19 | Japan Science And Technology Agency | Method for the determination of absolute configuration of chiral compounds |
| US7736902B2 (en) | 2003-02-06 | 2010-06-15 | Japan Science And Technology Agency | Method for determination of absolute configuration of chiral compounds |
| WO2007088947A1 (en) | 2006-02-02 | 2007-08-09 | National University Corporation NARA Institute of Science and Technology | Circular dichroism fluorescent microscope |
| EP1980842A4 (en) * | 2006-02-02 | 2011-01-05 | Nat Univ Corp Nara Inst | FLUORESCENT MICROSCOPE WITH CIRCULAR DICHROISM |
| US8098428B2 (en) | 2006-02-02 | 2012-01-17 | National University Corporation NARA Institute of Science and Technology | Circular dichroism fluorescent microscope |
| CN112782122A (en) * | 2019-11-04 | 2021-05-11 | 北京大学 | Device and method for measuring chirality of one-dimensional material |
| CN112782122B (en) * | 2019-11-04 | 2022-03-11 | 北京大学 | A device and method for measuring the chirality of one-dimensional materials |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Prendergast et al. | Synthesis, spectral properties, and use of 6-acryloyl-2-dimethylaminonaphthalene (Acrylodan). A thiol-selective, polarity-sensitive fluorescent probe. | |
| Huo et al. | A turn-on green fluorescent thiol probe based on the 1, 2-addition reaction and its application for bioimaging | |
| CN110982518B (en) | Nitrogen-sulfur co-doped carbon quantum dot fluorescent probe for cysteine detection and preparation and application thereof | |
| Liu et al. | A hemicyanine-based colorimetric and ratiometric fluorescent probe for selective detection of cysteine and bioimaging in living cell | |
| CN115850174B (en) | A fluorescent probe for detecting amines and its preparation method and application | |
| Oguz et al. | A basket-type fluorescent sensor based calix [4] azacrown ether for multi-analytes: Practicability in living cells and real sample | |
| Zhang et al. | Complexation of polysaccharide and monosaccharide with thiolate boronic acid capped on silver nanoparticle | |
| Lee et al. | A colorimetric and fluorometric polydiacetylene biothiol sensor based on decomposition of a pyridine-mercury complex | |
| Maupin et al. | The measurement of circular polarization in the near-IR luminescence from chiral complexes of Yb (III) and Nd (III) | |
| Dinh et al. | Room temperature phosphorimetry as a new spectrochemical method of analysis | |
| Markina et al. | Surface-enhanced raman spectroscopy for the determination of medical and narcotic drugs in human biofluids | |
| JPH112606A (en) | Chirality analysis method | |
| JP4085443B2 (en) | Amino acid analysis reagent and amino acid analysis method | |
| Gamoh et al. | A boronic acid derivative as a highly sensitive fluorescence derivatization reagent for brassinosteroids in liquid chromatography | |
| CN113563222A (en) | Method for detecting hydrogen peroxide based on surface enhanced Raman scattering of silent zone reporter molecule and application | |
| CN105588823A (en) | Preparation and application of fluorescent switch type sensor for detecting biological thiols | |
| Long et al. | Synthesis of CdTe quantum dots-based imprinting fluorescent nanosensor for highly specific and sensitive determination of caffeic acid in apple juices | |
| CN113340867B (en) | Method for detecting tyrosinase by using colorimetric-SERS double-readout sensor | |
| Alasiri et al. | Ratiometric detection of dopamine using NIR carbon dots and Alizarin red S-boronic acid complex: A competitive displacement approach | |
| Li et al. | Vibrational spectroscopic studies of mesna and dimesna | |
| Winefordner et al. | Phosphorimetric determination of procaine, phenobarbital, cocaine, and chlorpromazine in blood serum, and cocaine and atropine in urine | |
| Aaron et al. | A Quantitative Photochemical-Fluorimetric Method for Measurement of Nonfluorescent Vitamin K1 | |
| CN113109311B (en) | Reagent and method for detecting Pi, neutral red and heparin in dual modes by using smart phone and visual test paper | |
| Wang et al. | Development and evaluation of a novel fluorescent chiral derivatization reagent DBD-SM-Pro: first observation of four chiral amino acids in human hair | |
| CN110554105B (en) | A kind of analytical method of chiral carboxylic acid compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040601 |
|
| A977 | Report on retrieval |
Effective date: 20051012 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20051108 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A02 | Decision of refusal |
Effective date: 20060228 Free format text: JAPANESE INTERMEDIATE CODE: A02 |